🔎 Trials Near Me

Home › Kanser sa Pancreas › Rhode Island

Pag-aaral pangklinika para sa Kanser sa Pancreas sa Rhode Island

6 pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa mga site sa Rhode Island.

Mga Lungsod sa Rhode Island

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Brown University Health Cancer Institute - Division of Hematology/Oncology, Providence
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07409272

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
Nagre-recruitObservasyonal na pag-aaral
Edad 50 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT04239573

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Rhode Island Hospital, Providence
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06958328

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

  • Brown University Cancer Institute, Providence
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT06850623

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Providence
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Rhode Island Hospital, Providence
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.